Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Am J Respir Cell Mol Biol ; 61(6): 702-712, 2019 12.
Article in English | MEDLINE | ID: mdl-31144984

ABSTRACT

Obesity is a risk factor for asthma, especially nonatopic asthma, and attenuates the efficacy of standard asthma therapeutics. Obesity also augments pulmonary responses to ozone, a nonatopic asthma trigger. The purpose of this study was to determine whether obesity-related alterations in gut microbiota contribute to these augmented responses to ozone. Ozone-induced increases in airway responsiveness, a canonical feature of asthma, were greater in obese db/db mice than in lean wild-type control mice. Depletion of gut microbiota with a cocktail of antibiotics attenuated obesity-related increases in the response to ozone, indicating a role for microbiota. Moreover, ozone-induced airway hyperresponsiveness was greater in germ-free mice that had been reconstituted with colonic contents of db/db than in wild-type mice. In addition, compared with dietary supplementation with the nonfermentable fiber cellulose, dietary supplementation with the fermentable fiber pectin attenuated obesity-related increases in the pulmonary response to ozone, likely by reducing ozone-induced release of IL-17A. Our data indicate a role for microbiota in obesity-related increases in the response to an asthma trigger and suggest that microbiome-based therapies such as prebiotics may provide an alternative therapeutic strategy for obese patients with asthma.


Subject(s)
Gastrointestinal Microbiome/physiology , Obesity/complications , Ozone/toxicity , Respiratory Hypersensitivity/etiology , Airway Resistance , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Asthma/etiology , Asthma/therapy , Cellulose/administration & dosage , Dietary Fiber/administration & dosage , Fecal Microbiota Transplantation , Female , Fermentation , Gastrointestinal Microbiome/drug effects , Germ-Free Life , Mice , Mice, Inbred C57BL , Mice, Obese , Obesity/genetics , Obesity/microbiology , Obesity/physiopathology , Pectins/administration & dosage , Pectins/therapeutic use , Receptors, Leptin/deficiency , Respiratory Hypersensitivity/chemically induced , Respiratory Hypersensitivity/diet therapy , Respiratory Hypersensitivity/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL